Skip to main content
. 2022 Aug;15(8):994–999. doi: 10.25122/jml-2022-0073

Table 1.

The percent of morbidities for study and control group.

Type of morbidity Study group n=50, No (%) Control group n=50, No (%) P-value Odds ratio C.I
Hypoglycemia 36 (72%) 4 (8%) 0.00*Sig. 29.5 8.9–97.5
Macrosomia 29 (58%) 6 (12%) 0.00005*Sig. 6.8 2.5–18.4
Neonatal jaundice (NNJ) 24 (48%) 13 (26%) 0.02*Sig. 2.6 1.1–6.1
Hypocalcemia 22 (44%) 3 (6%) 0.00001*Sig. 12.3 3.3–44.9
Transient tachypnea of the newborn (TTN) 21 (42%) 16 (32%) 0.3**N.S 1.5 0.6–3.4
Polycythemia 16 (32%) 2 (4%) 0.0002*Sig. 11.3 2.4–52.3
Respiratory Distress Syndrome (RDS) 13 (26%) 11 (22%) 0.6**N.S. 1.2 0.5–3.1
Prematurity 9 (18%) 9 (18%) 1**N.S 1 0.4–2.8
Coronary heart disease (CHD) 5 (10%) 1 (2%) 0.09**N.S 5.4 0.6–48.3
Birth injury 3 (6%) 0 (0%) 0.07**N.S - -
Birth asphyxia 2 (4%) 12 (24%) 0.003*Sig. 0.13 0.028–0.63 Protective
*

Sig. – significant; **N.S – not significant.